| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $8.5M | +21.0% | +56.2% |
| SG&A Expense | $4.7M | +13.4% | +42.1% |
| Operating Income | -$13.2M | -18.2% | -50.8% |
| Interest Expense | $161K | -31.8% | -66.9% |
| Net Income | -$11.3M | -135.0% | -5.9% |
| EPS (Basic) | -$0.21 | -133.3% | +36.4% |
| EPS (Diluted) | -$0.21 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $87.0M | -13.6% | +425.2% |
| Current Assets | $90.1M | -13.0% | +398.4% |
| Total Assets | $93.6M | -11.7% | +335.0% |
| Current Liabilities | $10.9M | -25.7% | -28.4% |
| Total Liabilities | $13.5M | -14.5% | -63.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.7M | — | — |
| Capital Expenditures | $178K | — | — |
| Investing Cash Flow | -$151K | — | — |
| Financing Cash Flow | $12.2M | — | — |
| Free Cash Flow | -$27.9M | — | — |
| -133.3% |
| +36.4% |
| $80.1M |
| -11.2% |
| +625.2% |